Pediatric Methylphenidate Exposures: 7-Year Experience of Poison Centers in the United States

2003 ◽  
Vol 42 (2) ◽  
pp. 159-164 ◽  
Author(s):  
Wendy Klein-Schwartz
2018 ◽  
Vol 56 (11) ◽  
pp. 1107-1114 ◽  
Author(s):  
S. L. Calcaterra ◽  
S. G. Severtson ◽  
G. E. Bau ◽  
Z. R. Margolin ◽  
B. Bucher-Bartelson ◽  
...  

2015 ◽  
Vol 35 (7) ◽  
pp. 705-712 ◽  
Author(s):  
MB Forrester

Poison centers advance knowledge in the field of toxicology through publication in peer-review journals. This investigation describes the pattern of poison center-related publications. Cases were poison center-related research published in peer-review journals during 1995–2014. These were identified through searching the PubMed database, reviewing the tables of contents of selected toxicology journals, and reviewing abstracts of various national and international meetings. The following variables for each publication were identified: year of publication, journal, type of publication (meeting abstract vs. other, i.e. full article or letter to the editor), and the country(ies) of the poison center(s) included in the research. Of the 3147 total publications, 62.1% were meeting abstracts. There were 263 publications in 1995–1999, 536 in 2000–2004, 999 in 2005–2009, and 1349 in 2010–2014. The publications were in 234 different journals. The journals in which the highest number of research was published were Clinical Toxicology (69.7%), Journal of Medical Toxicology (2.2%), and Veterinary and Human Toxicology (2.1%). The research was reported from 62 different countries. The countries with the highest number of publications were the United States (67.9%), United Kingdom (6.5%), Germany (3.9%), France (2.5%), and Italy (2.4%). The number of publications increased greatly over the 20 years. Although the publications were in a large number of journals, a high proportion of the publications were in one journal. While the research came from a large number of countries, the preponderance came from the United States.


1985 ◽  
Vol 7 (1) ◽  
pp. 11-26

Poisoning is an important cause of accidental death in children less than 5 years of age. The most frequently ingested poisons are those that are commonly available at home in pleasant-colored containers and are easily accessible. They are usually in containers that are not child-proof. Mouthwash contains varying concentrations of ethanol ranging from a high of 26.9% (53.8 proof) to 14% (28 proof). A potentially lethal dose of absolute ethanol is approximately 3 g/kg (3.8 mL/kg) in a small child. [See Table in the PDF] During an 18-month period, reports of 422 cases of mouthwash ingestions by children less than 6 years of age were collected by The National Poison Center Network from its member poison centers in selected areas of the United States (unpublished data, 1979).


2020 ◽  
Vol 58 (7) ◽  
pp. 669-675 ◽  
Author(s):  
Amy McDonald ◽  
Leslie Francis ◽  
Barbara Insley Crouch ◽  
Mollie Cummins

2017 ◽  
Vol 57 (3) ◽  
pp. 266-276 ◽  
Author(s):  
Sofia Rakowsky ◽  
Henry A. Spiller ◽  
Marcel J. Casavant ◽  
Thiphalak Chounthirath ◽  
Nichole L. Hodges ◽  
...  

This study used the National Poison Data System database to retrospectively analyze the characteristics and medical outcomes of exposures to antipyretic medications involving children younger than 6 years in the United States. From 2000 through 2015, United States Poison Control Centers recorded an average of 74 387 antipyretic exposures annually among children younger than 6 years. Most exposures involved ibuprofen (55.1%) or acetaminophen (40.1%). From 2000 to 2009, the number of exposures increased by 73.0%, followed by a 25.2% decrease from 2009 to 2015. Children exposed to acetaminophen had 1.98 times higher odds of a serious medical outcome compared with those exposed to ibuprofen. Although generally safe at the correct dosage, antipyretic exposures continue to cause pediatric morbidity and, in rare cases, death. Prevention efforts should focus on reducing child access; educating caregivers about the potential dangers of antipyretics; and discouraging their use, except when needed to improve a child’s comfort.


2014 ◽  
Vol 33 (10) ◽  
pp. 993-999 ◽  
Author(s):  
A Pourmand ◽  
P Armstrong ◽  
M Mazer-Amirshahi ◽  
H Shokoohi

Over the past decade, emerging drugs of abuse and synthetic derivatives of more traditional agents have flooded the market. While Europe was the first to experience a surge in the use of drugs such as synthetic cathinones and cannabinoids, poison centers throughout the United States have seen a dramatic rise in calls related to these new designer drugs of abuse. In the majority of cases, care is largely supportive but significant medical and traumatic complications may occur. Providers must be aware of the ever-changing trends in abuse, so that they may optimally care for poisoned patients.


Sign in / Sign up

Export Citation Format

Share Document